3 Recruiting HCC Phase 2 Clinical Trials

Active phase 2 studies for hcc enrolling across the USA. Verify eligibility and contact site coordinators.

All HCC studies

Phase 2 Studies for HCC

🔵 Active, Not Recruiting Phase1 / Phase2

GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC

📍 Johns Hopkins Hospital — Baltimore, Maryland

View Study & Checklist ➔

🟢 Recruiting Phase2

Y-90 Treatment Response Using Transarterial Radioembolization

📍 Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania

View Study & Checklist ➔

🟢 Recruiting Phase2

Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC

📍 Emory University — Atlanta, Georgia

View Study & Checklist ➔